跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EPCLUSA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
EPCLUSA
Authorized
STANDARD
EPCLUSA
gilead sciences canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
01a0cf499928e8bf
Company
gilead sciences canada inc
Type
Standard
Approval Details
Approval Id
01a0cf499928e8bf
Drug Approval Canada Name
EPCLUSA
Product Name
EPCLUSA
Status
Marketed
Status Date
2016-08-02
Original Market Date
2016-08-02
Din
02456370
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:18.40.24
Atc Original
J05AP55 SOFOSBUVIR AND VELPATASVIR
Atc Name
j 05 ap 55
Aig Number
0258270001
Company Name
gilead sciences canada inc
Company Address
400, 6925 Century Avenue, Mississauga, Ontario, Canada, L5N 7K2
Active Ingredients
SOFOSBUVIR
400 MG
VELPATASVIR
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
01a0cf499928e8bf
Type
Standard
Back to Health Canada Approvals